XNYS · Healthcare · Medical Instruments & Supplies
Teleflex Inc is a provider of medical technology products focused on enhancing clinical benefits, improving patient and provider safety and reducing total procedural costs. It designs, develops, manufactures and supply medical devices used by hospitals and healthcare providers supporting high-acuity emergent procedures. The company has three reportable segments: Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). It derives maximum revenue from Americas. Its products includes: Anaesthesia, Emergency Medicine, Interventional Cardiology/Radiology, Interventional Urology - UroLift System, Surgery, Urology, and Vascular Access.
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-05-07 | Q1 2026 | 1.22 | 1.39 | +13.93% | $548.3M | ✅ Beat | +6.22% | -1.06% | — |
| 2026-02-26 | Q4 2025 | 3.74 | 1.93 | -48.40% | $569.0M | ❌ Miss | -3.37% | -1.22% | -2.35% |
| 2025-11-06 |
| Q3 2025 |
| 3.38 |
| 3.67 |
| +8.58% |
| $913.0M |
| ✅ Beat |
| — |
| — |
| — |
| 2025-07-31 | Q2 2025 | 3.36 | 3.73 | +11.01% | $780.9M | ✅ Beat | +7.72% | -3.36% | +5.78% |
| 2025-05-01 | Q1 2025 | 2.88 | 2.91 | +1.04% | $700.7M | ✅ Beat | +0.43% | +0.25% | -4.93% |
| 2025-02-27 | Q4 2024 | 3.88 | 3.89 | +0.26% | $795.4M | ✅ Beat | -4.57% | -2.05% | -0.66% |
| 2024-10-31 | Q3 2024 | 3.39 | 3.49 | +2.95% | $764.4M | ✅ Beat | +5.05% | -1.51% | -3.36% |
| 2024-08-01 | Q2 2024 | 3.33 | 3.42 | +2.70% | $749.7M | ✅ Beat | +0.50% | -2.52% | +3.77% |
Showing last 8 quarters.